While these approaches remain important, they often fail to address the deeper hormonal and metabolic mechanisms that regulate body weight
2 Development of GIP receptor antagonists GIP was identified in the 1970s (56) and first described as an enterogastrone that inhibited gastric acid secretion in dogs, and, thus, initially named gastric inhibitory peptide (57)
To overcome this limitation, GLP-1 analogs have undergone extensive structural modifications to render them resistant to degradation while replicating the pharmacological functions [6, 7]
Oral Semaglutide (Wegovy Pill) The Wegovy pill brings the convenient option of oral GLP-1 weight loss to those who prefer pills over injections, demonstrating a similar efficacy to its injectable counterpart
Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors
249 Non-histone protein lactylation is also implicated in ischemic stroke